Additionally, expression of functional PBRM1 has been shown to restrain VHL loss-driven ccRCC progression, thus illustrating the existence of distinct subtypes of VHL-null ccRCC [43]. Here, PBRM1 is linked to nonpapillary renal cell carcinoma.